Interest expense will spike and cash flows will drop for most low-rated healthcare companies this year, Moody’s Investor Service said in a March 22 report.
Read the full post on Becker's Hospital Review - Healthcare News
Moody's: Interest expense will jump 20% for most low-rated healthcare companies in 2023
